Ask AI
Personalizing EBC

CE / CME

Personalizing Treatment for Early-Stage Breast Cancer: Where We Are and Where We Are Headed

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: July 15, 2026

Expiration: January 14, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How many people with breast cancer do you provide care for in a typical month?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

A 56-year-old postmenopausal woman has node-positive, high-risk ER-positive/HER2-negative early breast cancer (EBC). She completed neoadjuvant chemotherapy followed by surgery. Germline BRCA1 and BRCA2 testing is negative.

Which adjuvant systemic treatment strategy is most appropriate?

4.

A 62-year-old woman with high-risk ER-positive/HER2-negative EBC is starting adjuvant ET with a CDK4/6 inhibitor after completing surgery and chemotherapy. She is concerned about treatment duration, adverse effects, and whether she will be able to stay on therapy while caring for her spouse.

Which communication approach is most appropriate to support adherence and persistence?